US Broker Ratings

Precigen, Inc. (PGEN) Stock Analysis: Unpacking a 113% Potential Upside in Biotech

Precigen, Inc. (NASDAQ: PGEN), a biotech innovator headquartered in Germantown, Maryland, is generating buzz in the healthcare sector with its cutting-edge gene and cell therapies. The..

Talkspace, Inc. (TALK) Stock Analysis: Exploring a 21% Upside Potential with Strong Revenue Growth

For investors seeking exposure in the digital health sector, Talkspace, Inc. (NASDAQ: TALK) presents a compelling opportunity. As a pioneer in virtual behavioral healthcare, Talkspace connects..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: A Healthcare Sector Gem with 46% Upside Potential

Sonida Senior Living, Inc. (NASDAQ: SNDA) stands as a noteworthy player within the healthcare sector, specifically in the niche of medical care facilities. With a market..

MeiraGTx Holdings plc (MGTX): Analyst Ratings Signal a Potential 184% Upside for Biotech Investors

MeiraGTx Holdings plc (NASDAQ: MGTX) is making waves in the biotechnology sector, capturing the attention of investors with its cutting-edge genetic medicines and a standout potential..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 255% Upside for Investors

Sana Biotechnology, Inc. (NASDAQ: SANA) is a compelling player in the biotechnology sector, with a focus on harnessing engineered cells to develop innovative treatments for diseases..

Immatics N.V. (IMTX) Stock Analysis: A Biotech Powerhouse with 128% Upside Potential

Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company, is making waves in the biotech sector with its innovative approach to cancer treatment. Headquartered in Tübingen, Germany,..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring a Promising 941% Upside Potential in Biotechnology

Upstream Bio, Inc. (NASDAQ: UPB) is a clinical-stage biotechnology company focusing on developing innovative treatments for inflammatory diseases, particularly severe respiratory disorders. Headquartered in Waltham, Massachusetts,..

COMPASS Pathways Plc (CMPS) Investor Outlook: Unpacking the 104% Potential Upside in Mental Health Innovation

In the rapidly evolving field of mental health treatment, COMPASS Pathways Plc (NASDAQ: CMPS) is making waves with its innovative approach. As a biotechnology firm headquartered..

Theravance Biopharma (TBPH) Stock Analysis: A Stable Play with a 3.74% Potential Upside

For investors navigating the healthcare sector, Theravance Biopharma, Inc. (NASDAQ: TBPH) presents a unique opportunity within the biotechnology industry. With a market capitalization of $884.18 million,..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: Exploring a Potential 596.67% Upside

Akebia Therapeutics, Inc. (NASDAQ: AKBA) is capturing the attention of investors with a striking potential upside of 596.67%, according to analyst ratings. This biopharmaceutical company, based..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Exploring a 69.59% Potential Upside in Biotech

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is capturing the attention of investors with its promising position in the biotechnology sector. As a clinical-stage biopharmaceutical company, Zenas BioPharma..

AxoGen, Inc. (AXGN) Stock Analysis: A 45.98% Potential Upside in the Healthcare Sector

AxoGen, Inc. (NASDAQ: AXGN), a pivotal player in the healthcare sector, is making waves in the medical devices industry with its focus on peripheral nerve regeneration..

Claritev Corporation (CTEV) Stock Analysis: Healthcare Innovator with Nearly 96% Upside Potential

Claritev Corporation (NASDAQ: CTEV) has emerged as a compelling player in the healthcare sector, specifically within the niche of Health Information Services. As the company continues..

Embecta Corp. (EMBC) Stock Analysis: Navigating Healthcare Challenges with a 3.89 Forward P/E

Embecta Corp. (NASDAQ: EMBC), a stalwart in the healthcare sector, presents a fascinating case for investors focused on medical instruments and supplies. With its roots tracing..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring an 80% Potential Upside in the Biotech Sector

Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage biotechnology company, has captured the attention of investors with its promising technology aimed at degrading disease-causing proteins. With a market..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Exploring a 78% Potential Upside in Biotech

Cogent Biosciences, Inc. (NASDAQ: COGT), a clinical-stage biotechnology company, is capturing the attention of investors with its focus on precision therapies for genetically defined diseases. The..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Exploring a 47.92% Potential Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotechnology company, is generating buzz among investors with its significant potential upside of 47.92%. This figure is driven by..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring a 101% Potential Upside

Vir Biotechnology, Inc. (NASDAQ: VIR), a prominent player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of over 101%. This clinical-stage..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: A Promising Biotech with 144% Potential Upside

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is making waves in the biotechnology sector, offering investors a compelling opportunity with a potential upside of 144.43%, according to analysts’..

AnaptysBio, Inc. (ANAB) Stock Analysis: Exploring a Biotech with 81.39% Potential Upside

Investors seeking opportunities in the healthcare sector should consider AnaptysBio, Inc. (NASDAQ: ANAB), a biotechnology firm that has gained significant attention due to its promising pipeline..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds